Hoi-Yeung Li

Hoi-Yeung Li

Auto-generated profile, based on publicly available information

Hoi-Yeung Li

School of Biological Sciences, Nanyang Technological University, Singapore

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2012 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
KCK-S Chan
K-S Chan
CKC-G Koh
C-G Koh
HLH-Y Li
H-Y Li
The strategy of clinically targeting cancerous cells at their most vulnerable state during mitosis has instigated numerous studies into the mitotic cell death (MCD) pathway. As the hallmark of cancer revolves around cell-cycle deregulation, it is not surprising that antimitotic therapies are effective against the abnormal proliferation of transformed cells. Moreover, these antimitotic drugs are also highly selective and sensitive. Despite the robust rate of discovery and the development of mitosis-selective inhibitors, the unpredictable complexities of the human body’s response to these drugs still herald the biggest challenge towards clinical success. Undoubtedly, the need to bridge the gap between promising preclinical trials and effective translational bedside treatment prompts further investigations towards mapping out the mechanistic pathways of MCD, understanding how these drugs work as medicine in the body and more comprehensive target validations. In this review, current antimitotic agents are summarized with particular emphasis on the evaluation of their clinical efficacy as well as their limitations. In addition, we discuss the basis behind the lack of activity of these inhibitors in human trials and the potential and future directions of mitotic anticancer strategies.

6 October 2011 in Blood
Verified
Journal Article
Open access
PDF file
RHRoyston-Luke Huang
Royston-Luke Huang
ZTZiqiang Teo
Ziqiang Teo
HCHan Chung Chong
Han Chung Chong
PZPengcheng Zhu
Pengcheng Zhu
MTMing Jie Tan
Ming Jie Tan
NTNguan Soon Tan
Nguan Soon Tan
Vascular disruption induced by interactions between tumor-secreted permeability factors and adhesive proteins on endothelial cells facilitates metastasis. The role of tumor-secreted C-terminal fibrinogen-like domain of angiopoietin-like 4 (cANGPTL4) in vascular leakiness and metastasis is controversial because of the lack of understanding of how cANGPTL4 modulates vascular integrity. Here, we show that cANGPTL4 instigated the disruption of endothelial continuity by directly interacting with 3 novel binding partners, integrin α5β1, VE-cadherin, and claudin-5, in a temporally sequential manner, thus facilitating metastasis. We showed that cANGPTL4 binds and activates integrin α5β1-mediated Rac1/PAK signaling to weaken cell–cell contacts. cANGPTL4 subsequently associated with and declustered VE-cadherin and claudin-5, leading to endothelial disruption. Interfering with the formation of these cANGPTL4 complexes delayed vascular disruption. In vivo vascular permeability and metastatic assays performed using ANGPTL4-knockout and wild-type mice injected with either control or ANGPTL4-knockdown tumors confirmed that cANGPTL4 induced vascular leakiness and facilitated lung metastasis in mice. Thus, our findings elucidate how cANGPTL4 induces endothelial disruption. Our findings have direct implications for targeting cANGPTL4 to treat cancer and other vascular pathologies.

1 March 2011 in Cancer Cell
Verified
Journal Article
Closed access
PZPengcheng Zhu
Pengcheng Zhu
MTMing Jie Tan
Ming Jie Tan
RHRoyston-Luke Huang
Royston-Luke Huang
CTChek Kun Tan
Chek Kun Tan
HCHan Chung Chong
Han Chung Chong
NTNguan Soon Tan
Nguan Soon Tan

2 December 2005 in Science
Verified
Journal Article
Closed access
PDF file
QVQueenie P. Vong
Queenie P. Vong
KCKan Cao
Kan Cao
HLHoi Y. Li
Hoi Y. Li
PIPablo Iglesias
Pablo Iglesias
YZYixian Zheng
Yixian Zheng
Proper chromosome segregation requires the attachment of sister kinetochores to microtubules from opposite spindle poles to form bi-oriented chromosomes on the metaphase spindle. The chromosome passenger complex containing Survivin and the kinase Aurora B regulates this process from the centromeres. We report that a de-ubiquitinating enzyme, hFAM, regulates chromosome alignment and segregation by controlling both the dynamic association of Survivin with centromeres and the proper targeting of Survivin and Aurora B to centromeres. Survivin is ubiquitinated in mitosis through both Lys 48 and Lys 63 ubiquitin linkages. Lys 63 de-ubiquitination mediated by hFAM is required for the dissociation of Survivin from centromeres, whereas Lys 63 ubiquitination mediated by the ubiquitin binding protein Ufd1 is required for the association of Survivin with centromeres. Thus, ubiquitinaton regulates dynamic protein-protein interactions and chromosome segregation independently of protein degradation.

24 April 2012 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
Clarence T. T. WongClarence T. T. Wong
Clarence T. T. Wong
DRDewi K. Rowlands
Dewi K. Rowlands
CWChi‐Hang Wong
Chi‐Hang Wong
TLTheodore W. C. Lo
Theodore W. C. Lo
GNGiang K. T. Nguyen
Giang K. T. Nguyen
JTJames Tam
James Tam

29 November 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
TWTobias Wunder
Tobias Wunder
SCSteven Le Hung Cheng
Steven Le Hung Cheng
SLSoak-Kuan Lai
Soak-Kuan Lai
HLHoi-Yeung Li
Hoi-Yeung Li
OMOliver Mueller-Cajar
Oliver Mueller-Cajar
The slow and promiscuous properties of the CO2-fixing enzyme Rubisco constrain photosynthetic efficiency and have prompted the evolution of powerful CO2 concentrating mechanisms (CCMs). In eukaryotic microalgae a key strategy involves sequestration of the enzyme in the pyrenoid, a liquid non-membranous compartment of the chloroplast stroma. Here we show using pure components that two proteins, Rubisco and the linker protein Essential Pyrenoid Component 1 (EPYC1), are both necessary and sufficient to phase separate and form liquid droplets. The phase-separated Rubisco is functional. Droplet composition is dynamic and components rapidly exchange with the bulk solution. Heterologous and chimeric Rubiscos exhibit variability in their tendency to demix with EPYC1. The ability to dissect aspects of pyrenoid biochemistry in vitro will permit us to inform and guide synthetic biology ambitions aiming to engineer microalgal CCMs into crop plants.